Cost of Anti-retroviral Medicines in Indonesia


Price of patented ARV before 2000 (per 60 tablets) (US$)

Price of patented ARV after 2000 (per 60 tablets) (US$)

Price of generic ARV after government-use authorization (per 60 tablets) (US$)

Lamivudine + zidovudine + nevirapine




Lamivudine (3TC)




Nevirapine (Viramune)




Lamivudine + zidovudine (Combivir)




*The range of subsidized and full-cost prices that patients have to pay.
**The price range in different pharmacies. Indonesia does not have price control on medicines and therefore pharmacies and hospitals charge different prices
Note: The brands of the patented ARVs are in brackets.

Source: Lutifyah and Hira (2006). Data obtained through interview with PT Kimia Farma, the Indonesian generic manufacturer. Cited in M Khor, “Patents, Compulsory Licenses and Access to Medicines: Some Recent Experiences,” Third World Network, 2009.

Kaletra or Aluvia (lopinavr+ritonavir marketed by Abbott Laboratories) costs $83.3 per patient per month, over $1,000 per patient per year for public programs. The private sector price is several times more. (Abbott Laboratories, November 2011)

Back to HIV/AIDS Treatment in Indonesia               Next to Funding for HIV/AIDS Initiatives

Back to Indonesia Action page

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.


To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.